Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ImmunoPET: Antibody-Based PET Imaging in Solid Tumors. | Front Med (Lausanne) | 2022 | 35836956 | PubTator, text mining | PubMed |
| Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment. | J Clin Transl Hepatol | 2022 | 35836772 | PubTator, text mining | PubMed |
| Innovative targets of the lncRNA-miR-mRNA network in response to low-dose aspirin in breast cancer patients. | Sci Rep | 2022 | 35835840 | PubTator, text mining | PubMed |
| Cardiac rehabilitation may influence leptin and VEGF A crosstalk in patients after acute coronary syndrome. | Sci Rep | 2022 | 35821400 | PubTator, text mining | PubMed |
| Assemblies of JAG1 and JAG2 determine tracheobronchial cell fate in mucosecretory lung disease. | JCI Insight | 2022 | 35819850 | PubTator, text mining | PubMed |
| Erratum: Two engineered site-specific antibody-drug conjugates, HLmD4 and HLvM4, have potent therapeutic activity in two DLL4-positive tumour xenograft models. | Am J Cancer Res | 2022 | 35812052 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Tissue Engineering Approaches to Uncover Therapeutic Targets for Endothelial Dysfunction in Pathological Microenvironments. | Int J Mol Sci | 2022 | 35806421 | PubTator, text mining | PubMed |
| Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting. | Stem Cells Int | 2022 | 35800881 | PubTator, text mining | PubMed |
| Angiogenesis in Spinal Cord Injury: Progress and Treatment. | Cureus | 2022 | 35800787 | PubTator, text mining | PubMed |
| Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication. | Cancer Drug Resist | 2022 | 35800375 | PubTator, text mining | PubMed |
| Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology. | Front Pharmacol | 2022 | 35784750 | PubTator, text mining | PubMed |
| Bone Engineering Scaffolds With Exosomes: A Promising Strategy for Bone Defects Repair. | Front Bioeng Biotechnol | 2022 | 35782499 | PubTator, text mining | PubMed |
| Notch signaling determines cell-fate specification of the two main types of vomeronasal neurons of rodents. | Development | 2022 | 35781337 | PubTator, text mining | PubMed |
| Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis. | Front Cell Dev Biol | 2022 | 35774228 | PubTator, text mining | PubMed |
| Hypoxia drives hematopoiesis with the enhancement of T lineage through eliciting arterial specification of hematopoietic endothelial progenitors from hESC. | Stem Cell Res Ther | 2022 | 35765115 | PubTator, text mining | PubMed |
| The dynamic roles of the bladder tumour microenvironment. | Nat Rev Urol | 2022 | 35764795 | PubTator, text mining | PubMed |
| KMT2D-NOTCH Mediates Coronary Abnormalities in Hypoplastic Left Heart Syndrome. | Circ Res | 2022 | 35762338 | PubTator, text mining | PubMed |
| Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases. | J Transl Med | 2022 | 35761337 | PubTator, text mining | PubMed |
| Toll-like receptor 3 gene regulates cataract-related mechanisms via the Jagged-1/Notch signaling pathway. | Bioengineered | 2022 | 35758265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=47